Navigation Links
RECITAL Study Presents Excellent Outcomes and Rapid Patient Recovery With Revolutionary Femoral Access Procedure
Date:12/1/2011

ore comfortable experience for the patient while reducing hospital resource use and overall cost per patient.

Separately, Arstasis announced the appointment of David I. Bruce to the position of President and CEO. The company's founder, Bruce Modesitt, who has been CEO since its inception in 2004, will focus on expanding the product platform as Chief Technology Officer.

"At this point in our company's history, we're delighted to attract a seasoned CEO with repeat successes in managing early market penetration for novel medical devices," commented Bruce Modesitt, "and I look forward to David's leadership in accelerating our business growth."

New CEO David Bruce said, "I'm pleased to be joining the Arstasis team as we announce the results of our first U.S. clinical trial. RECITAL demonstrates the Arstaotomy procedure helps minimize complications, speed recovery and enable earlier discharge. With our investigators and initial customers showing outstanding results, we are positioned to achieve broader adoption into the ten million arterial catheterization procedures performed worldwide each year."

The AXERA™ Access Device is a breakthrough femoral artery access tool that quickly creates a long, ultra-low angle arteriotomy, the Arstaotomy, resulting in significant tissue-upon-tissue overlap in the artery wall. The Arstaotomy procedure requires minimal manual compression to provide secure arterial closure with no foreign body implants thereby eliminating the risk of infections and thromboembolic events related to vascular implants.

Arstasis, Inc. is headquartered in Redwood City, CA. Additional information about the RECITAL Study, Arstaotomy procedure and AXERA Access Device is available at www.arstasis.com.

CONTACT:
Mark Page
Sr. Director, Marketing
Arstasis, Inc.
650-508-1549


'/>"/>
SOURCE Arstasis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in XIAFLEX® Study for Frozen Shoulder Syndrome
2. Ceregene Completes Enrollment of Second Phase 2 Study of CERE-120 for the Treatment of Parkinsons Disease
3. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
4. BioMarin Initiates Phase 2 Study for GALNS in Patients Under Five Years of Age With MPS IVA
5. New Study Points to Novel Mechanism by Which Tumors Escape Recognition by the Immune System
6. Inspiration Biopharmaceuticals Initiates Second Pivotal Clinical Study of Innovative Hemophilia Therapy OBI-1
7. Cara Therapeutics Initiates Phase I Study with Oral Formulation of Novel Peripherally-Acting Kappa Opioid Agonist
8. Updated Survival Data from Study Comparing TTF™ (Tumor Treating Fields) Therapy to Best Standard Chemotherapy for Recurrent Glioblastoma Reported at the 16th Annual Scientific Meeting of the Society for NeuroOncology
9. Perceptive Informatics® Global Survey Results Indicate Wide Use of Industry-Standard Medical Imaging Metrics to Meet Study Milestones
10. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
11. goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 2015 According to a new ... (Consumables, Instruments, Services), by Test Type (Indirect, Enzyme-based, Reactive ... by End Users - Global Forecast to 2020", published ... to reach $736.85 Million by 2020 from $452.36 Million ... Browse 71 market data Tables and 90 ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
(Date:5/22/2015)... Richmond Pharmacology is a ... a worldwide reputation for excellence in clinical trials. ... peer reviewed medical journals. Its officers are engaged ... discussions about rules for transparency and publication of ... , Clinical research is conducted worldwide, ...
Breaking Medicine Technology:Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... England Journal of Medicine the B.E.S.T,study conducted in ... DISEASE CAN BE CONTROLLED,SUCCESSFULLY” , Prof. Fabbri: “Daily ... million 200 thousand people”.,Chiesi’s commitment to pneumological research ... to the daily dose,of cortisone necessary for the ...
... in AACR Cancer Journal , AUSTIN, Texas--(BUSINESS WIRE)--May ... of,data describing the dramatic clinical benefit of its ... inherited form of cancer known as,Li-Fraumeni Syndrome (LFS), ... p53 tumor suppressor gene. This is the,first reported ...
Cached Medicine Technology:Mild Asthma, a Revolutionary Therapy from Italian Research 2Mild Asthma, a Revolutionary Therapy from Italian Research 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4
(Date:5/22/2015)... May 22, 2015 In an effort ... and Sons is offering to donate $5 dollars for ... AC unit or water softening system. Customers have their ... and Sons gets business; and the Special Olympics receives ... Special Olympics helps over 4.4 million athletes, and boasts ...
(Date:5/22/2015)... In April 2006, Veatch Consulting opened for ... they have concentrated their focus to working with over ... of this growth and their goals to better serve ... Colorado, Cleveland, Ohio, Houston, Texas and now Dallas, Texas. ... offices, dental start ups, orthodontic practices, pediatric dental practices, ...
(Date:5/22/2015)... A new program for the "In ... field of Physical Therapy. , James Earl Jones ... out of physical therapy and discusses how the exercises ... a variety of ailments and injuries. Physical therapists ... plan that enhances daily activities such as house cleaning ...
(Date:5/22/2015)... Puritan Medical Products, a Maine manufacturer ... environmental, and forensics industries celebrates 96 years of ... US. At a time when countless manufacturing companies ... remains committed to designing and manufacturing their extensive ... , Since 1919, Puritan has focused on the ...
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The ... letter calling on religious leaders to make changes in order ... on his blog, discusses the history of war, how it ... it. Yisrayl says mankind was created to lead peaceful, joyful ... society. , “Yahweh created mankind, according to His Plan, ...
Breaking Medicine News(10 mins):Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2
... Va., Oct. 8 The U.S. Centers for Disease Control ... which specializes in public safety research and consulting, recently ... in 10 nations. , The study found many ... fire deaths and injuries in these nations. These best ...
... ... Electronic Payment Exchange (EPX), a leading merchant acquirer and payment processor, ... best practices provides welcome leadership to merchants, technology professionals, and vendors ... EPX is the first payment processor to offer a true end-to-end ...
... ... cell culture media, cell separation products and ancillary reagents for life science research, is ... , ... (PRWEB) October 8, 2009 -- STEMCELL Technologies Inc. (STEMCELL), a leader in specialty cell ...
... ONRAD, Inc. of ... of San Diego, California. ONRAD will be providing 24x7x365 coverage of diagnostic ultrasound interpretations ... , ... 2009 -- ONRAD, Inc. is pleased to announce its new relationship with La ...
... ... free of any detectable malignancy after using a new treatment offered by NeoPlas Innovation. ... Nashville, Tenn. (PRWEB) October 7, ... of any detectable malignancy after using a new treatment offered by NeoPlas Innovation . ...
... Richard Merkin, High Desert Medical Group and Heritage Health Care ... October 1 at the Antelope Valley Fairgrounds. Seniors lined up ... screenings including screenings for bone density, cholesterol, glucose, blood pressure, ... The theme for this year,s Senior Expo was "Life ...
Cached Medicine News:Health News:International Study Finds New Best Practices to Reduce Fire Casualties 2Health News:Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 2Health News:Electronic Payment Exchange Welcomes New Visa Best Practices for Data Field Encryption 3Health News:STEMCELL Technologies Inc. Announces Direct Distribution to Spain 2Health News:ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego, CA 2Health News:Inoperable Colon Cancer Resolved After Four Months of New Treatment 2Health News:Inoperable Colon Cancer Resolved After Four Months of New Treatment 3Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 2Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 3Health News:High Desert Medical Group, CEO Dr. Richard Merkin, Host Over 4,000 Seniors at 19th Annual Senior Health Expo, Discuss Savings Using Electronic Medical Records... 4
Carl Zeiss has created a special configuration of the OPMI pico surgical microscope for neurosurgical applications, combining the benefits of optical excellence and superb illumination with outstandi...
... The Leica MS2 is designed to ... well as multidisciplinary use. The Leica MS2 ... Leica M500 N with a innovative stand ... electromagnetic brakes, patented ABC balancing system for ...
Galilean Loupes...
... field-of-view enables high-quality full-coverage body imaging. New ... architecture. New powerful Quasar Dual gradients designed ... to 80 mT/m SR 200. New ... exploit the power of 3.0T in a ...
Medicine Products: